By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Proton pump inhibitors > Dexlansoprazole > Dexlansoprazole Dosage
Proton pump inhibitors
https://themeditary.com/dosage-information/dexlansoprazole-dosage-11141.html

Dexlansoprazole Dosage

Drug Detail:Dexlansoprazole (Dexlansoprazole [ dex-lan-soe-pra-zol ])

Drug Class: Proton pump inhibitors

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Erosive Esophagitis

Healing of Erosive Esophagitis (EE): 60 mg orally once a day

  • Duration of therapy: Up to 8 weeks

Maintenance dose: 30 mg orally once a day
  • Duration of therapy: Up to 6 months

Comments:
  • Patients may be given maintenance doses for the relief of heartburn.
  • Controlled studies for maintenance therapy did not extend beyond 6 months.

Uses:
  • Healing of all grades of EE
  • Maintenance of healed EE
  • Relief of heartburn

Usual Adult Dose for Gastroesophageal Reflux Disease

30 mg orally once a day

  • Duration of therapy: 4 weeks

Use: Treatment of heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD)

Usual Pediatric Dose for Erosive Esophagitis

12 years and older:
Healing of EE: 60 mg orally once a day

  • Duration of therapy: Up to 8 weeks

Maintenance dose: 30 mg orally once a day
  • Duration of therapy: Up to 6 months

Comments:
  • Patients may be given maintenance doses for the relief of heartburn.
  • Controlled studies of maintenance therapy did not extend beyond 16 weeks.

Uses:
  • Healing of all grades of EE
  • Maintenance of healed EE
  • Relief of heartburn

Usual Pediatric Dose for Gastroesophageal Reflux Disease

12 years and older: 30 mg orally once a day

  • Duration of therapy: 4 weeks

Use: Treatment of heartburn associated with symptomatic non-erosive GERD

Renal Dose Adjustments

No adjustment recommended

Liver Dose Adjustments

Mild liver dysfunction (Child-Pugh A): No adjustment recommended.
Moderate liver dysfunction (Child-Pugh B): 30 mg orally once a day for up to 8 weeks
Severe liver dysfunction (Child-Pugh C): Not recommended.

Precautions

CONTRAINDICATIONS:

  • Hypersensitivity to the active component or any of the ingredients
  • Use with rilpivirine-containing products

Safety and efficacy have not been established in patients younger than 12 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • This drug can be taken without regard to food.
  • This drug should not be chewed; it should be swallowed whole.
  • For patients that have difficulty swallowing capsules, the contents of a capsule can be sprinkled on applesauce, or dissolved in 20 mL of water and withdrawn into an oral syringe. Administer immediately into the mouth. Refill the syringe with 10 mL of water, swirl gently and administer. Repeat this step one more time.

Administration with water via a nasogastric tube:
  • Open the capsule and dissolve the content in 20 mL of water.
  • Withdraw the entire mixture into a catheter-tip syringe, swirl the syringe gently in order to keep the granules from settling, and immediately inject the mixture through the nasogastric tube into the stomach.
  • Do not save the water and granule mixture for later use.
  • Refill the syringe with 10 mL of water, swirl gently, and flush the tube.
  • Refill the syringe again with 10 mL of water, swirl gently, and administer.

General:
  • Two, 30 mg tablets are not interchangeable with one, 60 mg tablet.

Patient advice:
  • Report immediately and seek care if diarrhea does not improve. This may be a sign of Clostridium difficile associated diarrhea.
  • Report immediately and seek care for any cardiovascular or neurological symptoms including palpitations, dizziness, seizures, and tetany as these may be signs of hypomagnesemia.
  • Advise patients to speak to their physician or health care professional if they are pregnant, intend to become pregnant, or are breastfeeding.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by